Effectiveness of L-Carnitine for the Treatment of Erythropoietin-Resistant Renal Anemia: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Open Access
- 4 February 2026
- journal article
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 36 (3) , 491-501
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Future Fund
- National Health and Medical Research Council (511335)
- Tasmanian Department of Health
- Cancer Council South Australia
- Cancer Council Australia
This publication has 31 references indexed in Scilit:
- Effect of l-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysisInternational Urology and Nephrology, 2021
- Carnitine and AcylcarnitinesClinical Pharmacokinetics, 2012
- Epoetin requirements predict mortality in hemodialysis patientsAmerican Journal of Kidney Diseases, 2004
- Practice recommendations for the use of L-Carnitine in dialysis-related carnitine disorder National Kidney Foundation Carnitine Consensus ConferenceAmerican Journal of Kidney Diseases, 2003
- Dialysis-related carnitine disorder and levocarnitine pharmacologyAmerican Journal of Kidney Diseases, 2003
- l-carnitine treatment of anemiaAmerican Journal of Kidney Diseases, 2003
- L-carnitine and erythropoietin requirements in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- l-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietinAmerican Journal of Kidney Diseases, 1995
- Recombinant Human Erythropoietin Treatment May Improve Quality of Life and Cognitive Function in Chronic Hemodialysis PatientsAmerican Journal of Kidney Diseases, 1989
- Effects of l-carnitine and palmitoylcarnitine on membrane fluidity of human erythrocytesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989